Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Racial Disparity in A1C Independent of Mean Blood Glucose in Children With Type 1 Diabetes

  1. Jodi L. Kamps, PHD1,2,
  2. James M. Hempe, PHD2,3 and
  3. Stuart A. Chalew, MD2,3,4
  1. 1Department of Psychology, Children's Hospital, New Orleans, Louisiana;
  2. 2Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana;
  3. 3Children's Hospital Research Institute for Children, New Orleans, Louisiana;
  4. 4Department of Endocrinology, Children's Hospital, New Orleans, Louisiana.
  1. Corresponding author: Jodi L. Kamps, jkamps{at}chnola.org.
Diabetes Care 2010 May; 33(5): 1025-1027. https://doi.org/10.2337/dc09-1440
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE Mean blood glucose (MBG) and MBG-independent factors both influence A1C levels. Race was related to A1C independent of MBG in adults. The goal of this study was to determine if racial disparity exists in A1C independent of MBG in children with diabetes.

RESEARCH DESIGN AND METHODS Participants included 276 children with type 1 diabetes. A1C and MBG were obtained from multiple clinic visits, and a hemoglobin glycation index (HGI) (an assessment of A1C levels independent of MBG) was calculated. A1C and HGI were analyzed controlling for age, diabetes duration, and MBG.

RESULTS African Americans had statistically significantly higher A1C (9.1 ± 0.1) and HGI (0.64 ± 0.11) than Caucasians (A1C 8.3 ± 0.1, HGI −0.15 ± 0.07) independent of covariates.

CONCLUSIONS Because of racial disparity in A1C, which is independent of MBG, we recommend that A1C and MBG be used together to make therapeutic decisions for children with diabetes.

Our group previously demonstrated that A1C levels are determined by mean blood glucose (MBG) and MBG-independent factors (1–3). Identification of MBG-independent factors that influence A1C levels is important for proper interpretation of A1C results and assessment of glycemic control in patients with diabetes, particularly because patients with higher than average A1C levels independent of MBG have greater risk of microvascular complications (2). Recent data from adults (4–8) indicate that ethnicity/race is associated with differences in A1C independent of MBG. Race may also be associated with variation in A1C levels in children with or without diabetes (9,10), although these findings were not shown to be independent of MBG. The goal of the current study was to determine if racial disparity exists in A1C independent of MBG in children with type 1 diabetes.

RESEARCH DESIGN AND METHODS

Participants included 276 children from Children's Hospital of New Orleans with type 1 diabetes who self-identified as either African American or Caucasian. Patient participation was approved by the relevant institutional review boards.

MBG and A1C were obtained from participant medical records between 2002 and 2008, and average values were calculated for each participant. MBG was calculated as the mean of self-monitored blood glucose data downloaded from strip-based patient glucose meters during periods of at least 30 days. Most A1C assays (98%) were performed at Children's Hospital by the DCA 2000+ Analyzer (78%) and later the VITROS 5,1 chemistry system. A few samples (2%) were measured at outside commercial reference laboratories. All assays reported results in National Glycohemoglobin Standardization Program (NGSP) equivalents (11). Statistical analysis indicated no differences in A1C by assay method.

Evidence for a glucose-independent effect of race on A1C was tested by using MBG as a covariate in the analysis, or in a separate statistical model using the calculated hemoglobin glycation index (HGI) described elsewhere in detail (1,2,12). HGI was calculated by subtracting the patient's predicted A1C from the observed A1C measured at each clinic visit. Predicted A1C was determined by inserting the patient's MBG into a population regression equation {A1C [%] = [MBG (mg/dl) × 0.021] + 4.3}. Patients were divided into low, moderate, and high HGI groups based on mean HGI tertile (33%) rank using predetermined delimiters (low HGI was <−0.41, high HGI was >0.26, and moderate HGI was equal to all values in between) (12).

Demographic results are presented as means (± 1 SD). Appropriate transformations were applied to variables that were not normally distributed before ANOVA, although findings using raw and transformed data were both statistically significant and results using raw data are presented.

RESULTS

Participants included 141 females (51.1%) and 198 Caucasians (71.7%) with a mean age of 12.5 years (± 3.6) and mean diabetes duration of 4.9 years (± 3.4). The mean number of clinic visits was 7.7 (± 2.8). Mean A1C was 8.5% (± 1.3), and mean HGI was 0.08 (± 1.08).

Participants were classified into HGI categories: low HGI (n = 89, 32.1%), moderate HGI (n = 94, 33.9%), and high HGI (n = 93, 33.7%). Results of χ2 analyses indicated significant differences in HGI group by race (P < 0.001) but not by sex. Specifically, 25.6% of African American children were in the low HGI group, 16.7% were in the moderate HGI group, and 57.7% were in the high HGI group. For Caucasian participants, 34.8% were in the low HGI group, 40.9% were in the moderate HGI group, and 24.2% were in the high HGI group.

ANOVA was also conducted to evaluate differences between African Americans and Caucasians. The analysis yielded significantly different results for participant age and MBG, with African Americans exhibiting older age (mean 13.2 years for African Americans, 12.2 years for Caucasians, P < 0.05) and higher MBG (mean 206 mg/dl for African Americans, 189 mg/dl for Caucasians, P < 0.001) but not longer diabetes duration (mean 5.1 years for African Americans, 4.8 years for Caucasians, P = 0.53).

Results of ANOVA also yielded statistically higher A1C and HGI for African Americans compared with Caucasians (Table 1, unadjusted results). ANCOVA also indicated significantly higher A1C (P < 0.001) and HGI (P < 0.001) for African Americans compared with Caucasians, even when controlling for participant age, diabetes duration, and MBG (Table 1, adjusted results).

View this table:
  • View inline
  • View popup
Table 1

Results of ANOVA/ANCOVA (controlling for MBG, participant age, and diabetes duration) evaluating differences in A1C and HGI between African American and Caucasian participants

CONCLUSIONS

This study demonstrates that African American children with diabetes have higher A1C levels than Caucasians independent of MBG. This finding extends similar observations in adults (7,8) to children with diabetes and suggests that race was a factor accounting for between-individual differences in A1C previously described by our group (9). Previous analyses suggest that between-individual differences in A1C independent of MBG are not due to red blood cell turnover (1) or artifacts in the measurement of A1C or calculation of MBG (12). Biological factors that may influence intracellular A1C levels independent of MBG include those that influence nonenzymatic glycation (e.g., pH, glucose transport, and oxidative status) or enzymatic deglycation (13,14). However, further research will be necessary to clarify the mechanism of racial disparity in A1C.

These results indicate that discrepancies exist in the information provided by MBG versus A1C, particularly for children from different racial groups, and that MBG or A1C alone may not provide complete information about metabolic status. Because A1C differences independent of MBG contribute to risk for microvascular complications (2), this finding may help explain why African Americans are at increased risk of diabetes complications (4,9,15). Given that MBG-independent disparity in A1C is unlikely to be modifiable by glucose-lowering agents, simply increasing insulin doses to achieve a lowered target A1C could lead to greater risk of hypoglycemia in African American patients. Evidence of higher A1C levels in African Americans independent of MBG also has implications for diagnosis of diabetes, whether diagnosis is based on blood glucose concentration or A1C. We recommend that both A1C and MBG be evaluated when making therapeutic decisions in individuals with diabetes, especially in African Americans, who, based on current results, exhibit a tendency for higher A1C levels at any given MBG.

Acknowledgments

This research was supported by a grant from the American Diabetes Association (7-04-CR-04); by the Department of Pediatrics, Louisiana State University Health Sciences Center; and by the Children's Hospital of New Orleans.

No potential conflicts of interest relevant to this article were reported.

Parts of this study were presented in poster format at the 69th Scientific Sessions of the American Diabetes Association, New Orleans, Louisiana, 5–9 June 2009.

We would like to express our appreciation to the patients who volunteered for this study and the staff of Children's Hospital laboratory and our diabetes nurses for their assistance with data collection.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received August 3, 2009.
    • Accepted February 8, 2010.
  • © 2010 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

References

  1. ↵
    1. Hempe JM,
    2. Gomez R,
    3. McCarter RJ Jr,
    4. Chalew SA
    : High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002; 16: 313– 320
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. McCarter RJ,
    2. Hempe JM,
    3. Gomez R,
    4. Chalew SA
    : Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004; 27: 1259– 1264
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. McCarter RJ,
    2. Hempe JM,
    3. Chalew SA
    : Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care 2006; 29: 352– 355
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Kirk JK,
    2. D'Agostino RB Jr,
    3. Bell RA,
    4. Passmore LV,
    5. Bonds DE,
    6. Karter AJ,
    7. Narayan KM
    : Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006; 29: 2130– 2136
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Kirk JK,
    2. Passmore LV,
    3. Bell RA,
    4. Narayan KM,
    5. D'Agostino RB Jr,
    6. Arcury TA,
    7. Quandt SA
    : Disparities in HbA1c levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2008; 31: 240– 246
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Herman WH,
    2. Dungan KM,
    3. Wolffenbuttel BHR,
    4. Buse JB,
    5. Fahrbach JL,
    6. Jiang H,
    7. Martin S
    : Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endorinol Metab 2009; 94: 1689– 1694
    OpenUrlCrossRefPubMed
  7. ↵
    1. Herman WH,
    2. Ma Y,
    3. Uwaifo G,
    4. Haffner S,
    5. Kahn SE,
    6. Horton ES,
    7. Lachin JM,
    8. Montez MG,
    9. Brenneman T,
    10. Barrett-Connor E
    : the Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30: 2453– 2457
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Selvin E,
    2. Zhu H,
    3. Brancati FL
    : Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 2009; 32: 828– 833
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Chalew SA,
    2. Gomez R,
    3. Butler A,
    4. Hempe J,
    5. Compton T,
    6. Mercante D,
    7. Rao J,
    8. Vargas A
    : Predictors of glycemic control in children with type 1 diabetes: the importance of race. J Diabetes Complications 2000; 14: 71– 77
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Saaddine JB,
    2. Fagot-Campagna A,
    3. Rolka D,
    4. Narayan KM,
    5. Geiss L,
    6. Eberhardt M,
    7. Flegal KM
    : Distribution of HbA1c levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 2002; 25: 1326– 1330
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Little RR,
    2. Rohlfing CL,
    3. Wiedmeyer HM,
    4. Myers GL,
    5. Sacks DB,
    6. Goldstein DE
    : the NGSP Steering Committee. The National Glycohemoglobin Standardization Program: a five-year progress report. Clin Chem 2001; 47: 1985– 1992
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Soros AA,
    2. Chalew SA,
    3. McCarter RJ,
    4. Shepard R,
    5. Hempe JM
    : Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 18 1 2010 [ Epub ahead of print]
  13. ↵
    1. Gould BJ,
    2. Davie SJ,
    3. Yudkin JS
    : Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 1997; 260: 49– 64
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Delpierre G,
    2. Collard F,
    3. Fortpied J,
    4. Van Schaftingen E
    : Fructosamine 3-kinase is involved in intracellular deglycation pathway in human erythrocytes. Biochem J 2002; 365: 801– 808
    OpenUrlPubMedWeb of Science
  15. ↵
    1. Arfken CL,
    2. Reno PL,
    3. Santiago JV,
    4. Klein R
    : Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diabetes Care 1998; 21: 792– 795
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes Care: 33 (5)

In this Issue

May 2010, 33(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Racial Disparity in A1C Independent of Mean Blood Glucose in Children With Type 1 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Racial Disparity in A1C Independent of Mean Blood Glucose in Children With Type 1 Diabetes
Jodi L. Kamps, James M. Hempe, Stuart A. Chalew
Diabetes Care May 2010, 33 (5) 1025-1027; DOI: 10.2337/dc09-1440

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Racial Disparity in A1C Independent of Mean Blood Glucose in Children With Type 1 Diabetes
Jodi L. Kamps, James M. Hempe, Stuart A. Chalew
Diabetes Care May 2010, 33 (5) 1025-1027; DOI: 10.2337/dc09-1440
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies
  • Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
  • Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
Show more Original Research

Clinical Care/Education/Nutrition/Psychosocial Research

  • Not Only Diabetes but Also Prediabetes Leads to Functional Decline and Disability in Older Adults
  • Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes
  • Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes
Show more Clinical Care/Education/Nutrition/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.